Form 4: SCYNEXIS CLO Scott Sukenick Granted 129,833 RSUs

SCYNEXIS Chief Legal Officer Scott Sukenick was granted 129,833 restricted stock units, vesting over three years starting February 28, 2026.

Summary

• Scott Sukenick, Chief Legal Officer of SCYNEXIS INC (SCYX), acquired 129,833 shares of Common Stock.
• These shares represent restricted stock units (RSUs) granted on January 29, 2026, with a transaction price of $0.
• The RSUs will vest one-third per year over three years, with vesting commencing from February 28, 2026.
• Following this acquisition, Sukenick beneficially owns a total of 574,539 shares of Common Stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with long-term shareholder value, without indicating any immediate operational changes.

Positives

• The grant of 129,833 restricted stock units to the Chief Legal Officer aligns management incentives with long-term shareholder value.
• The three-year vesting schedule demonstrates a commitment to retaining key executives and fostering long-term performance.

Future Outlook

The grant of restricted stock units with a future vesting schedule indicates a long-term retention strategy for a key executive, aligning their future compensation with the company's performance over several years.

Industry Context

StockSavvy.ai notes that equity compensation, particularly restricted stock units with multi-year vesting, is a standard practice across the biotechnology and pharmaceutical industries to incentivize and retain senior leadership, aligning their interests with the company's long-term performance.

Comparison to Industry Standards

• Equity grants to senior executives like Chief Legal Officers are common in the biotech sector, comparable to practices at companies such as Moderna or Pfizer, where long-term incentives are used to retain talent and encourage sustained performance.
• The three-year vesting schedule for RSUs is a standard industry practice for executive compensation plans, promoting executive retention and long-term focus.

Stakeholder Impact

• Shareholders: Aligns the Chief Legal Officer's interests with long-term shareholder value through equity ownership.
• Employees: May signal stability in executive leadership and a commitment to long-term incentive programs.

Next Steps

• Vesting of restricted stock units will occur one-third per year over three years, starting February 28, 2026.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a key executive, which is a standard practice for executive compensation and retention. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as it maintains the current stance based on existing company fundamentals.

Keywords

SCYNEXIS, SCYX, Scott Sukenick, Chief Legal Officer, Restricted Stock Units, RSU, Equity Compensation, Insider Ownership, Form 4, Beneficial Ownership